Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Why is glyceryl trinitrate (GTN) administered sublingually?

To avoid first-pass metabolism. Explanation:1. Why Option A is Correct:Glyceryl Trinitrate (GTN) undergoes extensive high first-pass metabolism in the liver (nearly 90-100% extraction ratio) [1, 2]. If taken orally, the drug is absorbed from the GI tract into the portal circulation and metabolized by hepatic enzymes before reaching the systemic circulation, rendering it ineffective [1, 2]. The sublingual route allows the drug to be absorbed directly through the oral mucosa into the systemic venous circulation (via the superior vena cava), bypassing the liver and ensuring high bioavailability [1].2. Why Other Options are Incorrect:Option B: While sublingual administration does provide a rapid onset of action (1–3 minutes) [2], the primary pharmacological reason for choosing this route over the oral route is the avoidance of metabolic degradation [1]. Rapid onset is a clinical benefit, but avoiding first-pass metabolism is the pharmacokinetic necessity.Option C: GTN is not inherently a gastric irritant; the route is chosen for pharmacokinetic stability, not to protect the stomach lining.Option D: Sublingual administration actually increases the risk of systemic side effects (like throbbing headache and hypotension) because it achieves higher plasma concentrations more quickly than oral administration.3. NEET-PG High-Yield Pearls:Drug of Choice: Sublingual GTN is the drug of choice for acute anginal attacks.Storage: GTN is volatile and light-sensitive; it must be stored in tightly closed, dark glass containers.Mechanism: It acts by releasing Nitric Oxide (NO), which increases cGMP, leading to dephosphorylation of myosin light chains and resulting in venodilation (reducing preload).Other drugs with high first-pass metabolism: Propranolol, Lidocaine, Salbutamol, and Morphine.

Q: What is the most general term for the process by which the amount of active drug in the body is reduced after absorption into the systemic circulation?

Elimination. **Explanation:** **Elimination** is the correct answer because it is the broad, overarching term that encompasses all processes leading to the termination of drug action and its removal from the body. Once a drug enters the systemic circulation, its concentration is reduced through two primary mechanisms: **Metabolism** (biotransformation, usually by the liver) and **Excretion** (physical removal, usually by the kidneys). Therefore, Elimination = Metabolism + Excretion. **Analysis of Incorrect Options:** * **Excretion (A):** This is a subset of elimination. It refers specifically to the physical removal of the drug or its metabolites from the body (via urine, bile, sweat, etc.). It does not account for the chemical inactivation of the drug (metabolism). * **First-pass metabolism (C):** This occurs *before* the drug reaches systemic circulation. It refers to the metabolism of a drug in the gut wall or liver during its first passage after oral absorption, which reduces bioavailability. * **Distribution (D):** This is the reversible transfer of a drug from the systemic circulation to the tissues. While it reduces the concentration of the drug in the plasma, it does not reduce the total "amount of active drug in the body." **High-Yield NEET-PG Pearls:** * **Clearance (CL):** The theoretical volume of plasma from which the drug is completely removed per unit of time. It is the most important parameter for calculating the **maintenance dose**. * **Zero-order Kinetics:** A constant *amount* of drug is eliminated per unit time (e.g., Alcohol, Phenytoin, Salicylates). * **First-order Kinetics:** A constant *fraction* of drug is eliminated per unit time (most drugs follow this). * **Steady State:** Reached after approximately **4 to 5 half-lives**.

Q: Which of the following is not an inducer of CYP3A4?

Erythromycin. The Cytochrome P450 (CYP) enzyme system is the primary pathway for hepatic drug metabolism. CYP3A4 is the most abundant isoform, responsible for metabolizing nearly 50% of all clinically used drugs. Why Erythromycin is the correct answer: Erythromycin is a potent inhibitor of CYP3A4, not an inducer. It binds covalently to the iron atom of the heme group in the enzyme, forming an inactive complex [1]. This inhibition leads to decreased metabolism and increased toxicity of co-administered substrates like Theophylline, Warfarin, and Statins [2]. Why the other options are incorrect: * A. Barbiturates (e.g., Phenobarbital): These are classic, broad-spectrum microsomal enzyme inducers [1]. They increase the synthesis of CYP enzymes (3A4, 2C9) by activating the Constitutive Androstane Receptor (CAR). * B. Glucocorticoids: Drugs like Dexamethasone act as inducers of CYP3A4 by binding to the Pregnane X Receptor (PXR), which upregulates enzyme transcription [2]. * C. Phenytoin: A potent inducer of multiple CYP isoforms, including 3A4 [1]. This often leads to significant drug-drug interactions, such as reducing the efficacy of oral contraceptives. High-Yield Clinical Pearls for NEET-PG: * Mnemonic for Inducers (GPRS Cell Phone): Griseofulvin, Phenytoin, Rifampicin, Smoking, Carbamazepine, Phenobarbital. (Note: St. John’s Wort is also a potent inducer [2]). * Mnemonic for Inhibitors (VITAMIN K): Valproate, Isoniazid, Terefenadine (historical), Amiodarone, Macrolides (except Azithromycin), Indinavir, Non-DHP CCBs (Verapamil/Diltiazem), Ketoconazole (and Cimetidine/Grapefruit juice [2]). * Key Distinction: Azithromycin is the only common macrolide that does not significantly inhibit CYP3A4.

Q: Antacids interfere with the absorption of which of the following drugs?

Azithromycin. **Explanation:** The absorption of various drugs is significantly influenced by gastric pH and the presence of multivalent cations (like $Al^{3+}$, $Mg^{2+}$, and $Ca^{2+}$) found in antacids. **Why Azithromycin is the Correct Answer:** Azithromycin absorption is unique among macrolides in that its **bioavailability is significantly decreased (by approximately 43%)** when administered concurrently with aluminum and magnesium-containing antacids. While the exact mechanism is a reduction in the rate of absorption ($C_{max}$), the clinical impact is substantial enough that patients are advised to take azithromycin at least 1 hour before or 2 hours after antacid consumption. **Analysis of Incorrect Options:** * **Oxytetracycline & Ofloxacin:** These drugs interact with antacids via **chelation**. They form insoluble complexes with multivalent cations ($Ca^{2+}, Mg^{2+}, Al^{3+}$), which prevents their absorption. While antacids *do* interfere with them, in the context of standard pharmacological teaching and specific exam patterns (like NEET-PG), Azithromycin is often highlighted due to its specific pharmacokinetic profile regarding peak serum concentrations. * **Ketoconazole:** This is an azole antifungal that requires an **acidic environment** for dissolution and absorption. Antacids increase gastric pH, thereby reducing its absorption. **NEET-PG High-Yield Clinical Pearls:** 1. **Chelation Rule:** Tetracyclines and Fluoroquinolones (like Ofloxacin) should not be taken with milk, antacids, or iron preparations due to chelation. 2. **pH Dependency:** Drugs like Ketoconazole, Itraconazole, and Iron salts require low pH; H2 blockers and PPIs significantly reduce their efficacy. 3. **The "Empty Stomach" Rule:** Most macrolides (except Clarithromycin) and Penicillins should be taken on an empty stomach for optimal absorption, but the specific interaction between Azithromycin and antacids is a frequent "trap" question.

Q: The maintenance dose of a drug is calculated using which pharmacokinetic parameter?

Clearance. **Explanation:** The goal of a **maintenance dose (MD)** is to maintain a steady-state concentration of a drug in the plasma, ensuring that the rate of drug administration equals the rate of drug elimination. **1. Why Clearance (A) is correct:** Clearance (CL) is the most important pharmacokinetic parameter for determining the maintenance dose. The mathematical relationship is: **Maintenance Dose = (Target Plasma Concentration × Clearance) / Bioavailability** Since clearance represents the volume of plasma cleared of the drug per unit of time, it directly dictates how much drug must be replaced to maintain equilibrium. **2. Why other options are incorrect:** * **Volume of Distribution (Vd):** This parameter is used to calculate the **Loading Dose**, not the maintenance dose. Vd determines how much drug is needed to fill the "reservoir" of the body to reach the target concentration rapidly. * **Oral Bioavailability (F):** While used in the calculation to adjust for the route of administration, it is a fraction that modifies the dose rather than the primary physiological driver of drug replacement. * **Daily Dosage:** This is a clinical instruction (the result of the calculation), not a pharmacokinetic parameter used to derive the dose. **High-Yield Clinical Pearls for NEET-PG:** * **Loading Dose (LD) Formula:** $LD = (Vd \times Cp) / F$ (where $Cp$ is target plasma concentration). * **Maintenance Dose (MD) Formula:** $MD = (CL \times Cp) / F$. * **Steady State:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration, regardless of the dose. * **Rule of Thumb:** If a patient has renal or hepatic impairment, the **Maintenance Dose** must be decreased (due to decreased Clearance), but the **Loading Dose** usually remains the same (unless Vd is altered).

Q: Which of the following hormones utilizes the JAK-STAT transducer mechanism?

Growth hormone. The **JAK-STAT (Janus Kinase-Signal Transducer and Activator of Transcription)** pathway is a distinct signaling mechanism used by receptors that lack intrinsic tyrosine kinase activity but associate with soluble tyrosine kinases [4]. **1. Why Growth Hormone (GH) is correct:** Growth hormone belongs to the **Cytokine Receptor Superfamily** [3]. When GH binds to its receptor, it induces dimerization, which activates cytoplasmic **JAK2** kinases [1]. These kinases phosphorylate the receptor and **STAT** proteins. The phosphorylated STATs then translocate to the nucleus to regulate gene transcription [5]. Other hormones using this pathway include Prolactin, Erythropoietin, and Leptin [2]. **2. Why the other options are incorrect:** * **Somatostatin:** Acts via **G-Protein Coupled Receptors (GPCR)**, specifically the $G_i$ subtype, which inhibits adenylyl cyclase and decreases cAMP levels. * **Insulin:** Utilizes a **Receptor Tyrosine Kinase (RTK)**. Unlike GH, the insulin receptor has *intrinsic* enzymatic activity (the receptor itself is a kinase) and primarily signals through the IRS-1/PI3K pathway. * **Adenosine:** Acts through **GPCRs** ($A_1, A_2, A_3$ receptors). $A_1$ is $G_i$-coupled (inhibitory), while $A_2$ is $G_s$-coupled (stimulatory). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for JAK-STAT:** "**PIGGLy**" — **P**rolactin, **I**mmunomodulators (Cytokines/Interferons), **G**rowth Hormone, **G**-CSF, **L**eptin/Erythropoietin. * **Laron Dwarfism:** Caused by a mutation in the Growth Hormone receptor, leading to defective JAK-STAT signaling despite high GH levels. * **Tofacitinib:** A JAK inhibitor used clinically in the treatment of Rheumatoid Arthritis [5].

Question 1

Why is glyceryl trinitrate (GTN) administered sublingually?

Accepted Answer

To avoid first-pass metabolism

Answer

For rapid onset of action

Answer

To prevent gastric irritation

Answer

To minimize side effects

Question 2

An intravenous bolus dose of thiopentone leads to loss of consciousness within 10-15 seconds. The patient regains consciousness in just a few minutes. This is because it is:

Accepted Answer

Redistributed from brain to other body tissues

Answer

Renally excreted

Answer

Exhaled rapidly

Answer

Rapidly metabolized by hepatic enzymes

Question 3

Which of the following are drug transport mechanisms?

Accepted Answer

Active transport

Answer

Passive transport

Answer

Lipid solubility

Answer

Bioavailability

Question 4

What is the most general term for the process by which the amount of active drug in the body is reduced after absorption into the systemic circulation?

Accepted Answer

Elimination

Answer

Excretion

Answer

First pass metabolism

Answer

Distribution

Question 5

What characterizes an agonist in terms of receptor binding and effect?

Accepted Answer

Has affinity for the receptor and exhibits intrinsic activity

Answer

Has affinity for the receptor but lacks intrinsic activity

Answer

Has affinity for the receptor and exhibits negative intrinsic activity

Answer

None of the above

Question 6

Which of the following is not an inducer of CYP3A4?

Accepted Answer

Erythromycin

Answer

Barbiturates

Answer

Glucocorticoids

Answer

Phenytoin

Question 7

Streptomycin single dose is more effective than multiple small doses because it is -

Accepted Answer

Concentration dependent lytic effect

Answer

Longer half-life

Answer

Not dependent on renal clearance

Answer

Tubular secretion and reabsorption is more

Question 8

Antacids interfere with the absorption of which of the following drugs?

Accepted Answer

Azithromycin

Answer

Ketoconazole

Answer

Oxytetracycline

Answer

Ofloxacin

Question 9

The maintenance dose of a drug is calculated using which pharmacokinetic parameter?

Accepted Answer

Clearance

Answer

Volume of distribution

Answer

Oral bioavailability

Answer

Daily dosage

Question 10

Which of the following hormones utilizes the JAK-STAT transducer mechanism?

Accepted Answer

Growth hormone

Answer

Somatostatin

Answer

Insulin

Answer

Adenosine

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?